India, April 22 -- AstraZeneca Pharma India Ltd., in collaboration with STEMI India announces the launch of India Coronary Conquest (ICC) 2026, a clinician led, national Complex PCI challenge that connects early to mid career interventional cardiologists. Through real world case presentations and transparent, peer reviewed critique, ICC focuses on intravascular imaging and physiology, guideline aligned decision making, complication management, and procedural safety to strengthen everyday practice.
In India, one in four people is likely to die of a chronic disease. Driven by a shared ambition to enhance care for people living with cardiovascular, renal, and metabolic conditions, AstraZeneca is supporting ICC to advance evidence based educat...